Joshua Burshtein
Dermatology · Chicago, ILNPI 1942959713
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,921 of the $5,543 with a category attached, or 88.8%. It is spread thinly across 27 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 96 payments — averaging $57.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$761
- AbbVie$550
- Sun Pharmaceutical Industries Inc.$504
- Sanofi$472
- Amgen$380
- Novartis$262
- plus $3K from 21 others
What the payments were for
- Food & beverage$4,92189%
- Education$62211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $761 |
| AbbVie | 9 | $550 |
| Sun Pharmaceutical Industries Inc. | 8 | $504 |
| Sanofi | 11 | $472 |
| Amgen | 6 | $380 |
| Novartis | 4 | $262 |
| Galderma Laboratories, L.p. | 3 | $254 |
| Janssen Scientific Affairs, LLC | 2 | $227 |
| Lilly USA, LLC | 4 | $217 |
| Pfizer | 3 | $214 |
| Sanofi-aventis U.S. LLC | 2 | $170 |
| Verrica Pharmaceuticals Inc. | 3 | $167 |
| E.r. Squibb & Sons, L.L.C. | 4 | $166 |
| Incyte Corporation | 3 | $166 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $138 |
| Blueprint Medicines Corporation | 2 | $135 |
| Mimedx Group, Inc. | 2 | $123 |
| Dermavant Sciences, Inc. | 1 | $117 |
| UCB, Inc. | 4 | $110 |
| Regeneron Healthcare Solutions, Inc. | 2 | $95 |
| Biofrontera Inc. | 1 | $61 |
| LEO Pharma Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $49 |
| Merz Pharmaceuticals, LLC | 1 | $43 |
| Boehringer Ingelheim | 1 | $42 |
| Merz North America, Inc. | 2 | $39 |
| Tactile Systems Technology Inc | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,543 in reported general payments places this provider in the 70th percentile of 606 dermatology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 18 | $838 |
| Clindamycin Phosphate | 13 | $678 |
| Triamcinolone Acetonide | 41 | $660 |
| Ketoconazole | 28 | $336 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Chicago
- Raj ChovatiyaChicago$3.6M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Omer IbrahimChicago$313K
- Caroline RobinsonChicago$308K
- Smita AggarwalChicago$214K
- Tracee BlackburnChicago$180K
- Faiyaaz KalimullahChicago$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.